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Introduction
COP (coat protein)-mediated trafficking in the early secretory 
pathway  and  clathrin-mediated  endocytosis  are  similar  pro-
cesses that involve dynamic cycles of vesicle budding and   
fusion. Each starts with assembly of a coat on a membrane 
(COPII, COPI, or clathrin), deformation of the membrane into a 
bud, and then fission to release the transport vesicle (Bonifacino 
and Glick, 2004). Targeting of the vesicle and uncoating pre-
cede vesicle fusion, which is mediated by SNARE proteins 
(Jahn  and  Scheller,  2006;  Wickner  and  Schekman,  2008;   
Südhof and Rothman, 2009). These processes involve significant 
changes in the curvature of the membrane, and proteins that bind 
specifically to highly curved membranes, including amphipathic 
lipid-packing sensor (ALPS) motifs and BAR domains, play 
important roles in regulation of vesicle budding fusion cycles 
(McMahon and Gallop, 2005; Frost et al., 2009; Drin and 
Antonny, 2010). The ALPS motif was originally identified in 
ArfGAP1, which hydrolyzes GTP on Arf1 in COPI vesicles, thus 
coupling release of the coat with completion of vesicle formation 
(Bigay et al., 2005; Mesmin et al., 2007). An ALPS motif is 
also found at the N terminus of the long coiled-coil (CC) tether 
GMAP-210, which is involved in trafficking within the early 
secretory pathway (Cardenas et al., 2009). The tethering re-
action of GMAP-210 has been reconstituted in vitro, showing 
that the N-terminal ALPS motif binds to small vesicles, whereas 
the C terminus binds to flatter membranes (Drin et al., 2008).
Several ALPS motifs are present in proteins that function 
in the early secretory pathway and the nuclear envelope (Drin et al., 
2007; Doucet et al., 2010). These membranes are characterized 
M
embrane curvature sensors have diverse struc-
tures  and  chemistries,  suggesting  that  they 
might have the intrinsic capacity to discrimi-
nate between different types of vesicles in cells. In this 
paper, we compare the in vitro and in vivo membrane-
binding properties of two curvature sensors that form 
very different amphipathic helices: the amphipathic lipid-
packing sensor (ALPS) motif of a Golgi vesicle tether and 
the  synaptic  vesicle  protein  -synuclein,  a  causative 
agent of Parkinson’s disease. We demonstrate the mech-
anism by which -synuclein senses membrane curvature. 
Unlike ALPS motifs, -synuclein has a poorly developed 
hydrophobic face, and this feature explains its dual sen-
sitivity  to  negatively  charged  lipids  and  to  membrane 
curvature. When expressed in yeast cells, these two cur-
vature sensors were targeted to different classes of vesi-
cles, those of the early secretory pathway for ALPS motifs 
and to negatively charged endocytic/post-Golgi vesicles 
in the case of -synuclein. Through structures with com-
plementary  chemistries,  -synuclein  and  ALPS  motifs   
target distinct vesicles in cells by direct interaction with 
different lipid environments.
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of vesicles. Our results support the conclusion that the AHs of 
ALPS motifs and -synuclein can discriminate different vesi-
cles in cells through direct interaction with a lipid environment 
complementary to each one’s distinctive chemistry.
Results
The GMAP-210 ALPS motif and  
-synuclein both cause accumulations  
of vesicles in cells
We expressed the N-terminal region of GMAP-210 (GMAPN) 
and  full-length  -synuclein  as  GFP  or  mCherry  fusions  in 
yeast cells (Fig. 1). GMAPN-mCherry and GMAPN-GFP local-
ized to cytoplasmic puncta (Figs. 1 A and S1 A), which EM 
revealed to be clusters of small vesicles (Fig. 1 B). -Synuclein–
GFP also localized to cytoplasmic structures composed of 
vesicles (Fig. 1, C and D), as has been reported previously 
(Gitler et al., 2008; Soper et al., 2008). The GMAPN structures 
were made up of a regular arrangement of vesicles 50 nm in 
diameter, which by immuno-EM analysis were shown to con-
tain the GMAPN-GFP protein (Figs. 1 E and S1 B). We deter-
mined the concentration of GMAPN-GFP in yeast cells to be 
7 µM (Fig. S1 C), giving a protein/phospholipid ratio of 
1:1,000 (see Materials and methods). Based on in vitro ex-
periments (Drin et al., 2008), this ratio is consistent with 
GMAPN binding to vesicles after their formation, rather than 
inducing them. Expression of either GMAPN or -synuclein 
led to a severe defect in cell growth (Fig. 1 F) and a significant 
slowing of ER to Golgi transport (Fig. S1 D). For -synuclein, 
our results are consistent with a previous study (Outeiro and 
Lindquist, 2003).
GMAPN and -synuclein vesicular structures differed in 
their position with respect to the cell periphery. GMAPN struc-
tures were randomly distributed throughout the cell (Figs. 1 A 
and S1 A): only 10% were located in close proximity to the cell 
periphery (Fig. S1 E). In contrast, 80% of -synuclein struc-
tures were tightly juxtaposed to the PM (Figs. 1 C and S1 E). 
When  GMAPN-mCherry  and  -synuclein–GFP  were  coex-
pressed together, distinct structures were observed, and they did 
not colocalize at early time points after induction (Fig. 1 G). 
These results indicate that expression of GMAPN and -synuclein 
in yeast cells leads to accumulation of clusters of small vesicles 
and is consistent with the idea that they bind to and trap vesicles 
in cells. However, they also suggest that the vesicles trapped by 
these two proteins are different.
Comparison of the ALPS motif and  
-synuclein lipid-binding properties in vitro
Examination of the amphipathic structures formed by GMAPN 
and -synuclein reveals striking differences (Fig. 2, A and B). 
The N-terminal region of -synuclein forms an amphipathic   
3–11 helix, with properties opposite to the amphipathic -helix 
formed by an ALPS motif, both in terms of electrostatics and 
hydrophobicity. The contrasting chemistries of GMAPN and   
-synuclein AHs suggest that they might be adapted to mem-
branes of different lipid composition, providing a straight-
forward explanation for their localization to different vesicular 
by a low surface charge, low levels of cholesterol, and phospho-
lipids with largely monounsaturated fatty acid side chains (van 
Meer et al., 2008). Another major lipid environment in the   
endomembrane system of eukaryotic cells, found in early endo-
somes, the TGN, and the plasma membrane (PM), has different 
physical properties. These membranes are rich in cholesterol, 
their phospholipids have predominantly saturated fatty acids, 
and they exhibit asymmetry, with the cytosolic leaflet enriched 
in  phosphatidylserine  (PS)  and  other  anionic  phospholipids 
(van Meer et al., 2008). The distinct lipid compositions of the 
ER–early Golgi and TGN–endosomal–PM membrane systems 
have been conserved in evolution (Schneiter et al., 1999), and 
recent data on the properties of transmembrane proteins suggest 
these two lipid environments are maintained as distinct entities, 
with a sharp transition occurring within the Golgi apparatus 
(Sharpe et al., 2010).
ALPS  motifs  bind  specifically  to  highly  curved  mem-
branes because they are unbalanced lipid-binding amphipathic 
helices (AHs), having a well-developed hydrophobic face but 
very few charged residues on their polar face (Drin et al., 2007). 
Unlike a typical AH, which uses both hydrophobic and electro-
static interactions to associate with membranes, the lack of 
charged residues on the polar face of an ALPS AH makes it 
solely dependent on the hydrophobic force for membrane asso-
ciation. Hence, an ALPS motif is unable to associate with a flat 
bilayer of physiological composition, and requires lipid-packing 
defects, such as those created upon bending the membranes of 
the early secretory pathway.
A protein that forms a very different type of AH has also 
been reported to bind preferentially to highly curved membranes 
(Davidson et al., 1998; Middleton and Rhoades, 2010). This 
protein, -synuclein, plays a central role in Parkinson’s disease, 
a debilitating neurodegenerative disorder (Auluck et al., 2010). 
The precise function of -synuclein in cells is not known, but it 
is expressed primarily in neurons, in which it localizes to synap-
tic vesicles (Kahle et al., 2000). -Synuclein is involved in 
maintaining the reserve pool of synaptic vesicles before release 
and may act as a regulator of synaptic vesicle fusion (Larsen   
et al., 2006; Burré et al., 2010). Like ALPS motifs, -synuclein 
is unfolded in solution but forms an AH upon contact with the 
appropriate membrane (Davidson et al., 1998). Spin labeling 
experiments have determined that -synuclein forms a long   
3–11 helix upon binding to membranes, with a highly regular 
repeated structure that features lysine residues at the interface 
between the polar and hydrophobic faces (Jao et al., 2008). In 
contrast to an ALPS motif, the hydrophobic face of -synuclein 
is restrained, consisting of small hydrophobic residues, such as 
valine, alanine, and even threonine. How this type of AH acts as 
a curvature sensor is not clear.
We  report  here  the  mechanism  by  which  -synuclein 
senses membrane curvature in vitro and compare it with that 
used by an ALPS motif. For in vivo experiments, we chose the 
yeast  system  because  neither  -synuclein  nor  the  GMAP-210 
ALPS motif has a yeast homologue, thus minimizing the occur-
rence of protein–protein interactions that could complicate 
analysis of their lipid-binding properties. In yeast cells, the GMAP-
210 ALPS motif and -synuclein are targeted to different types 91 Curvature sensors bind vesicles selectively • Pranke et al.
Fig. 2 (C and D) compares the fluorescence emission spec-
tra of GMAPN and -synuclein with or without size-calibrated   
liposomes made exclusively of neutral lipids (egg phosphatidylcho-
line [PC]/palmitoyl oleoyl phosphatidylethanolamine [POPE] = 
7:3; cholesterol/phospholipids = 1:5). Although GMAPN bound 
to these liposomes in a sharply curvature-dependent manner   
(Fig. 2 C, partition coefficients in bottom inset), -synuclein was 
unable to bind to these liposomes, except for weak binding to the 
smallest ones (radius = 31 nm; Fig. 2 D). Similar results were ob-
tained with liposomes of a composition similar to that of Golgi 
membranes (“Golgi mix”), which contain a relatively low fraction 
of anionic lipids (5 mole percent [mol%] PS and 10 mol% phospha-
tidylinositol; Fig. S2 A). These results indicate that the ALPS motif, 
but not -synuclein, is adapted to curved membranes containing 
low amounts of anionic lipids and even to neutral liposomes.
PS is the major anionic lipid of eukaryotic cellular mem-
branes and is known to favor the binding of -synuclein (Davidson   
et al., 1998). As observed previously for other ALPS motifs, we 
observed no major change in the binding properties of GMAPN 
by the introduction of POPS (Fig. S2 B). In striking contrast, the 
introduction of increasing amounts of POPS at the expense of 
structures in yeast cells (Fig. 1). Nevertheless, what remains 
disconcerting is the fact that if both ALPS motifs and -synuclein 
recognize membrane curvature, two very different chemistries 
can lead to the same function.
To compare the lipid-binding properties of GMAPN and 
-synuclein in vitro, we used constructs similar to those ex-
pressed in yeast except that they were not fused to a fluorescent 
protein but were covalently labeled with a lipid-sensitive fluor-
escent probe (NBD; Johnson, 2005) through a cysteine intro-
duced at the beginning of the AH (Fig. 2, A and B). Experiments 
were conducted by incubating the NBD-labeled constructs with 
liposomes of defined size and composition and by immediately 
recording the fluorescence emission spectrum of the mixture.   
A low protein/lipid ratio (1:600 to 1:1,200) was used to minimize 
surface-crowding effects. Titration experiments showed that the 
fluorescence of NBD increased 4.5-fold for GMAPN and 10-fold 
for -synuclein upon liposome binding (see next two paragraphs). 
Note that GMAPN is a dimer. Hence, it uses two ALPS motifs   
to bind to lipid membranes, which corresponds to 38 × 2 = 76 aa 
(Fig. 2 A), a number comparable with the continuous 90 aa AH 
of -synuclein (Fig. 2 B).
Figure 1.  GMAPN and -synuclein cause accumulations of distinct vesicular structures in yeast cells. (A, top) Schematic diagram of GMAPN-mCherry 
(mCh). (bottom) Localization of this construct in yeast cells. (B) Representative transmission EM images of cells expressing GMAPN-GFP. (C, top) Sche-
matic diagram of -synuclein–GFP. (bottom) Localization in yeast cells. (D) Representative EM image of cells expressing -synuclein–GFP. (E) Immuno-
gold labeling of cells expressing GMAPN-GFP using antibodies against GFP. Arrows show vesicular structures. N, nucleus; V, vacuole; ER, endoplasmic 
reticulum; CW, cell wall. (F) Strains IPY4 GMAPN-GFP and IPY5 -synuclein (-syn)–GFP were grown overnight under repressing conditions and then 
shifted (open symbols) or not shifted (closed symbols) to induction medium for the indicated times, and absorbance (Abs) of the cultures at OD600 was 
monitored. (G) Localization of GMAPN-mCherry and -synuclein–GFP expressed together in wild-type yeast cells. (top and bottom) Two optical sections 
of a z stack obtained for a single cell. BY4742 cells carrying the indicated proteins on plasmids were grown overnight (A–E) or for 4 h (G) under 
inducing conditions and imaged.JCB • VOLUME 194 • NUMBER 1 • 2011   92
the paucity of charged residues (Fig. 2 A). These features are 
responsible for the high sensitivity of ALPS motifs to mem-
brane curvature because introducing positively charged residues 
at the two edges of the polar face strongly reduces their curva-
ture  sensitivity  (Drin  et  al.,  2007).  -Synuclein  represents   
a striking counterexample to this rule, as its polar face displays 
an almost perfect distribution of positively charged residues 
at its two edges (Fig. 2 B). This poses the question of how   
-synuclein senses membrane curvature.
Although opposite in chemistry, -synuclein and the ALPS 
motif share the property of being unbalanced AHs, with either 
the charged or hydrophobic face being much less developed 
than that of classical AHs. We hypothesized that -synuclein 
is a curvature sensor because of its poor hydrophobic face and 
sought to test this model by enhancing the hydrophobicity of 
this face. We chose to mutate the six threonine residues that are 
regularly spaced along the -synuclein helix and that, when 
POPC in small liposomes dramatically increased the binding of 
-synuclein (Fig. 3 A). Conversely, when liposomes of varying 
radii and containing a constant amount of POPS (60 or 30 mol%) 
were used, we observed that -synuclein bound to liposomes in a 
sharply size-dependent manner (Figs. 3 B, partition coefficients in 
inset; and S2 C). The binding of -synuclein was so sensitive to 
both PS and membrane curvature that the amount of PS required   
for binding decreased dramatically when the liposome radius 
changed only a small amount, from a mean of 48 to 30 nm (Fig. 3 A, 
right). These direct in vitro comparisons of ALPS motifs and   
-synuclein demonstrate that they have similar responses to mem-
brane curvature but different lipid requirements for binding.
Mechanism by which -synuclein senses 
membrane curvature
ALPS motifs are defined by the abundance of small and un-
charged residues (Ser, Thr, and Gly) on their polar face and by 
Figure 2.  GMAPN, but not -synuclein, is a sensor of the curvature of neutral lipid membranes. (A and B) Structural features of the ALPS motif of GMAP-
210 (aa 1–38) and of the -synuclein AH and principles of the liposome-binding experiments. (A) The ALPS motif of GMAP-210 is assumed to form a 
perfect  helix. The structure of -synuclein is from recent electron paramagnetic resonance experiments (Jao et al., 2008). (B) For clarity, only two 11-mer 
repeats (aa 9–30) are shown, but the remainder of the AH displays the same features. Yellow: Ala, Val, Leu, Ile, Met, Phe, and Trp. Pink: Ser, Thr, and Gly. 
Red: Asp and Glu. Blue: Lys and Arg. Green: other residues. To monitor lipid binding, the constructs were labeled with NBD on a cysteine at the beginning 
of the AH (mutations M1C in GMAPN and V3C in -synuclein). The drawing is approximately to scale for a liposome of radius (R) = 30 nm. (C and D) Emis-
sion fluorescence spectra of [NBD]GMAPN (C) or [NBD]-synuclein (D; 125 nM each) with or without calibrated neutral liposomes obtained by extrusion 
through polycarbonate filters of defined pore size or sonication (150 µM phospholipids; egg PC/POPE = 7:3; cholesterol/phospholipids = 1:5). (top insets) 
Fluorescence level at 530 nm as a function of liposome radius (as determined by dynamic light scattering). The horizontal lines indicate the fluorescence 
level in the absence of liposomes. (C, bottom inset) Fluorescence at 530 nm of 125 nM [NBD]GMAPN as a function of phospholipid concentration. Color 
coding for sonicated and extruded liposomes is indicated on the left. Calculation of partition coefficients is as previously described (see Materials and 
methods; Mesmin et al., 2007). N, N terminus; C, C terminus.93 Curvature sensors bind vesicles selectively • Pranke et al.
liposomes (Fig. S3 A), which have the most unfavorable fea-
tures for the binding of wild-type -synuclein. These results 
demonstrate that the poor hydrophobic face of the -synuclein 
AH is required for both its curvature-sensing capacity and its 
sharp dependency on anionic lipids.
To examine the in vivo properties of the T6 -synuclein 
mutant,  we  expressed  this  mutant  in  yeast  cells.  Wild-type   
-synuclein localizes to the PM in addition to vesicular struc-
tures (Fig. 1, C and G), as has been shown previously (Auluck 
et al., 2010). PM binding is mediated by the C-terminal region 
of -synuclein and is likely caused by protein–protein inter-
actions with PM-localized proteins (see following section of 
Results). Strikingly, only 2% of yeast cells expressing the   
T6 mutant had vesicular structures, in contrast to more than 40% 
of cells expressing wild-type -synuclein (Fig. S3, B and C).   
T6 -synuclein localized primarily to the PM, indicating strong 
targeting to membranes (Fig. S3, C and D). Hence, the capacity 
seen on a helical projection, are positioned right in the middle 
of the hydrophobic face (Fig. 3 C). Threonine, although gener-
ally considered as a polar residue, has some hydrophobic char-
acter because of its methyl group. Replacing each threonine 
by a phenylalanine or a leucine should considerably increase 
the hydrophobicity of the nonpolar face. The lipid-binding 
properties of the sextuple T6 mutant was assessed using the 
same liposomes as those used for the wild-type form, that is, 
liposomes of fixed size and varying amounts of POPS or lipo-
somes of varying size and a fixed amount of POPS. The sextu-
ple mutation changed completely the lipid-binding properties 
of -synuclein. Whereas the wild-type form exhibited strong 
dependencies on both liposome charge and membrane curva-
ture (Fig. 3, A and B), the T6 mutant bound to all liposomes 
regardless of the amount of POPS present and on the size of 
the liposome (Fig. 3, D and E). One striking observation was 
that the T6 mutant could even bind efficiently to large neutral 
Figure 3.  The ability of -synuclein to sense the curvature of negatively charged lipid membranes depends on its poorly developed hydrophobic face. 
(A) Binding of wild-type -synuclein to small liposomes containing increasing amounts of POPS (0–80 mol%) at the expense of POPC (80–0 mol%). The 
remaining phospholipid was egg PC (20 mol%) and the cholesterol/phospholipid ratio was 1:2. The liposomes were obtained by extrusion through 30-nm 
polycarbonate filters. The plot reports the fluorescence at 530 nm as determined from the spectra shown on the left as well as from an experiment performed 
with sonicated liposomes of the same composition. The extruded and sonicated liposomes displayed radii in the range of 46–53 and 23–48 nm, respec-
tively. (B) Binding of wild-type -synuclein to size-calibrated charged liposomes (egg PC/POPS = 4:6; cholesterol/phospholipids = 1:2). The three symbols 
used in the right plot correspond to three independent experiments. (inset) Fluorescence (fluo) of 125 nM [NBD]-synuclein as a function of phospholipid 
concentration. Color coding for sonicated and extruded liposomes is indicated on the left. Calculation of partition coefficients is described in Materials and 
methods. (C) Sequence of the AH region of -synuclein highlighting the repeating character of this region, which can be divided into 11-mer repeats. The 
mutations harbored by the T6 mutant consist in replacing all threonine residues (pink; left) of the nonpolar region by a more hydrophobic residue (Leu or 
Phe, yellow; right). Position of mutated residues in the 11-mer repeats is boxed (wild type; left) or shaded (mutant; right). Color coding is as in Fig. 2; in 
the alignment only mutated and charged residues are colored. (D) Binding of T6 mutant -synuclein to small liposomes containing increasing amounts of 
POPS at the expense of POPC as in A. (E) Binding of T6 mutant -synuclein to size-calibrated charged liposomes as in B. Concentrations in A, B, D, and E 
of proteins were 125 nM and phospholipids were 150 µM. Data in A and D were fitted (dashed lines) to a sigmoidal function (y = a + bx
n/(c + x
n)). The 
dashed lines in B and E were simply used to illustrate the apparent shape of the curve for binding as a function of liposome radius.JCB • VOLUME 194 • NUMBER 1 • 2011   94
significant proportion did contain Snc1p and Sso1p, which   
mediate fusion of secretory vesicles with the PM (Fig. 4 B). 
Colocalization with GMAPN could either be caused by their 
presence as cargo in COPII vesicles or to the presence of late 
secretory vesicles in GMAPN structures. The former hypothesis 
is strongly supported by the fact that Sec4p, a Rab protein local-
ized to post-Golgi secretory vesicles, did not colocalize with 
GMAPN to a significant extent, whereas most GMAPN struc-
tures did contain the early Golgi Rab Ypt1p (Fig. 4 B). Hence, 
GMAPN structures contain markers specific to vesicles of the 
early secretory pathway.
Given the proximity of -synuclein structures to the cell 
periphery, we tested whether they colocalized with peripheral 
ER, using the reticulon Rtn1p as a marker of this compartment 
(Voeltz et al., 2006). Although -synuclein structures were ad-
jacent to Rtn1p patches at the cell periphery, there was little, if 
any, overlap (Fig. S4, B and C). To determine whether -synuclein 
or GMAPN structures contain endocytic membranes, cells were 
treated with FM4-64, a marker of the endocytic pathway. GMAPN 
structures did not colocalize with FM4-64, even after long chase 
of -synuclein to sense membrane curvature, caused by the un-
balanced nature of its AH, is important for its ability to accumu-
late clusters of vesicles in yeast cells.
GMAPN and -synuclein colocalize with 
different membrane markers in yeast cells
To  determine  whether  GMAPN  structures  contain  COPII  or 
COPI vesicles, we tested colocalization with their cargo mole-
cules, including the ER-Golgi cargo receptor Emp47p, the COPII 
vesicle cargo pro–-factor, and the cis-Golgi enzyme Anp1p 
(Wooding and Pelham, 1998; Lee et al., 2004). A high percent-
age of GMAPN structures contained these markers (Figs. 4 A 
and S4 A). However, colocalization experiments with subunits 
of the COPII and COPI coats, as well as with clathrin, revealed 
little, if any, overlap with GMAPN (Fig. S4, B and C), support-
ing the conclusion that they are made up of uncoated vesicles. 
Three ER-Golgi SNAREs (Bos1p, Bet1p, and Sec22p) were pres-
ent in a large fraction of GMAPN structures, but the fourth mem-
ber of this SNARE complex, Sed5p, was not (Fig. 4 B). GMAPN 
structures did not contain endosomal or vacuolar SNAREs, but a 
Figure 4.  GMAPN and -synuclein structures colocalize with distinct compartment markers in yeast. (A) Localization in SEY6210 cells of GMAPN-mCherry 
with either GFP-Emp47p or pro–-factor–citrine and of Anp1p–monomeric RFP (mRFP) with GMAPN-GFP. (top) Representative images of colocalization of   
GMAPN-mCherry and GFP-Emp47p. (bottom) For quantifications, between 30 and 100 GMAPN structures were scored for the presence or absence of the   
cargo protein, and percentages were calculated (see Materials and methods). (B) Localization in SEY6210 cells of GMAPN-mCherry with the indicated 
GFP-tagged protein. Quantifications were performed as in A. (C) Localization in BY4742 of GMAPN-GFP or -synuclein–GFP (-syn) with FM4-64.   
(D–F) Localization in BY4742 of GMAPN-mCherry or -synuclein–mCherry with GFP-tagged charge probes carrying the indicated number of lysine 
residues. Quantifications (D) and representative images (E and F) are shown. Cells were grown overnight at 23°C (A–C) or 16°C (D–F) under inducing 
conditions, and then, live cells were imaged and quantified. Means and SDs of at least three independent experiments are shown. Outlines of cells are 
indicated by dashed lines. Bars, 2 µm.95 Curvature sensors bind vesicles selectively • Pranke et al.
of endocytosis (Fig. 6 E). Examination of cells expressing the 
-synuclein chimera by EM revealed striking accumulations of 
small vesicles at the cell periphery (Fig. 6, F and G). Vesicles 
were present in structures closely juxtaposed to the PM (Fig. 6 F) 
and, in some cells, were found in a single layer along the PM at 
a fixed distance (Fig. 6 G).
The -synuclein chimera specifically 
colocalizes with endocytic and post-Golgi 
vesicle markers
Although  we  found  significant  differences  in  colocalization 
patterns between GMAPN and -synuclein, we also found a 
lack  of  specificity  in  the  membranes  accumulated  within   
-synuclein structures (Fig. S5 A) as has been reported previ-
ously (Gitler et al., 2008; Soper et al., 2011). These results 
imply either that -synuclein binds nonspecifically to many 
types of vesicles in cells or that it binds specifically to one class 
of vesicle, and colocalization with other markers is a secondary 
effect. Experiments with the -synuclein chimera support the 
latter hypothesis. In contrast to full-length -synuclein, the chi-
mera  structures  did  not  contain  either  the  early  endosomal 
SNARE Tlg2p or the ER SNARE Use1p (Fig. S5 B). At early 
time points after induction, <5% of the -synuclein chimera 
structures colocalized with early Golgi markers (Fig. 7, A and C). 
In  contrast,  Snc1p  and  the  endocytic  marker  FM4-64  co-
localized with the -synuclein chimera to a high level, even   
after short periods of induction (Figs. 7, B and C; and S5 B). At 
early time points after induction, 40% of -synuclein chi-
mera structures contained the secretory vesicle marker Sec4p, 
and Ypt1p was present in 70–80% of chimera structures, likely 
because of its role in trafficking within the endocytic pathway 
(Sclafani et al., 2010).
We examined the localization of the -synuclein chimera 
in several endocytosis mutants and found a marked effect in 
sla2 cells. In sla2 mutants, there is a dramatic slowing of the 
internalization step of endocytosis, and scission of endocytic 
vesicles is blocked (Kaksonen et al., 2003). Many sla2 cells 
did not accumulate chimera-GFP–labeled structures, and those 
that did had significantly fewer structures than in wild-type cells 
(Fig. S5 C).
As described previously (Auluck et al., 2010), -synuclein 
localizes to the PM in addition to vesicular structures, but we   
did not observe PM localization of the -synuclein chimera 
(Figs. 6 and 7). -Synuclein interacts with protein partners, in-
cluding the synaptic vesicle SNARE synaptobrevin, via its acidic 
C terminus (Auluck et al., 2010; Burré et al., 2010). In co-
immunoprecipitation experiments, we found that the -synuclein   
chimera did not interact with the yeast homologue of synapto-
brevin, Snc1p, whereas full-length -synuclein did (Fig. S5 D), 
supporting the conclusion that protein–protein interactions con-
tribute to PM localization of full-length -synuclein in yeast.
Membrane targeting mechanism in cells
To address the question of whether targeting of GMAPN and 
the  -synuclein  chimera  to  distinct  membranes  occurred 
through protein–protein or protein–lipid interactions in cells, 
we used several approaches. Previous work has shown that   
times, at which point the dye was localized primarily to vacuoles 
(Fig. 4 C). In contrast, -synuclein structures almost all con-
tained FM4-64–labeled membranes (Fig. 4 C).
Surface charge biosensors, farnesylated peptides that con-
tain varying numbers of positively charged amino acids fused to 
GFP, bind to membranes of different levels of negative charge 
(Yeung  et  al.,  2008). When  coexpressed  with  GMAPN  or   
-synuclein,  opposite  colocalization  patterns  were  observed. 
Almost all GMAPN structures colocalized with the +2 probe 
with progressively fewer containing the more highly charged 
probes (Fig. 4, D and E). In contrast, only a small fraction of   
-synuclein structures contained the +2 probe, whereas essen-
tially all contained the +8 probe (Fig. 4, D and F). Because   
-synuclein binds to PS-containing vesicles in vitro, we tested the   
PS-specific probe LactC2 (Yeung et al., 2008) and found that it 
colocalized to a high level with -synuclein but not with GMAPN 
(Fig. S4 D). These results support the conclusion that in cells, as 
in vitro, -synuclein preferentially binds to negatively charged 
membranes, whereas GMAPN does not require a charge for 
membrane binding.
The ALPS motif and the N-terminal 
region of -synuclein act as localization 
determinants in yeast cells
The ALPS motif of GMAPN is required for its localization in 
yeast cells because deleting it renders the truncated protein   
cytosolic (Fig. 5 A). In contrast, when the CC region of GMAPN 
(aa 39–377) was replaced with a portion of the CC of the nu-
clear cohesin Smc1p (Haering et al., 2002), membrane targeting 
was not affected. The CC of Smc1p on its own localized primar-
ily to the nucleus, but when the ALPS motif was appended to 
the N terminus, the chimeric protein was localized to cytoplas-
mic puncta (Fig. 5 B). EM analysis indicated that cells express-
ing this ALPS–Smc1-CC chimera contained accumulations of 
vesicles (Fig. 5 C). Hence, the GMAP-210 ALPS motif acts as 
a localization determinant in yeast cells and is responsible for 
the accumulation of vesicular structures.
Comparison of GMAPN and -synuclein localization is 
complicated by their different structures: GMAPN is a CC dimer 
presenting two copies of a 38-aa-long AH, whereas -synuclein 
is a monomer with a 90-aa-long AH and an acidic tail. To create 
a perfectly matched pair, we constructed a chimera in which the 
38-aa ALPS motif of GMAPN was replaced with the first 38 aa 
of -synuclein (Fig. 6 A). The -synuclein chimera was found 
in patches of fluorescence at the cell periphery (Fig. 6 A, right), 
in striking contrast to the randomly dispersed cytoplasmic 
puncta in cells expressing GMAPN (Fig. 6 A, left). Like full-
length -synuclein, and unlike GMAPN, the chimera colocal-
ized to a very high level with the endocytic marker FM4-64, and 
-synuclein chimera structures did not overlap Rtn1p structures 
(Fig. 6, B and C). In addition, we found a high percentage of 
chimera  structures  colocalizing  with  the  fluid  phase  marker   
Lucifer yellow, another marker of the endocytic pathway (Fig. 6, 
B and C). Also like -synuclein, the -synuclein chimera did 
not colocalize with coats (Fig. S4 E), and its expression severely 
inhibited yeast growth (Fig. 6 D). Like -synuclein, and unlike 
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motif was replaced by its inverted sequence (invALPS-GMAP; 
Fig. 8). We reasoned that if the ALPS motif is localized via a 
protein–lipid interaction, inverting the sequence of the ALPS 
motif should not affect its capacity to localize to vesicles in cells 
because the chemical features of the AH are preserved (Fig. 8 A). 
Such an inversion should, however, compromise protein–protein 
interactions, as the inverted sequence shares little homology 
with the original ALPS sequence.
Cells expressing invALPS-GMAP accumulated structures 
to the same extent and in a cellular distribution identical to that of 
GMAPN (Fig. 8, B and C). These structures were composed of 
small vesicles, indistinguishable from those found in cells express-
ing the original GMAPN protein (Fig. 8 B). Importantly, the   
ER–Golgi  cargo  receptor  Emp47p  and  ER–Golgi  SNAREs 
Sec22p and Bet1p colocalized to the same extent with the in-
vALPS-GMAP structures as they did with wild-type GMAPN, 
whereas  invALPS-GMAP  structures  did  not  colocalize  with   
-synuclein and proteins containing ALPS motifs can interact 
with SNARE proteins (Rein et al., 2002; Burré et al., 2010; 
Thayanidhi et al., 2010), and both GMAPN and -synuclein 
chimera vesicular structures colocalized with SNAREs (Figs. 4 B 
and 7). However, our attempts to coimmunoprecipitate ER–
Golgi SNAREs and GMAPN from yeast cells were unsuccess-
ful, suggesting that there is not a strong interaction between 
them. Similar results were obtained for the -synuclein chi-
mera and Snc1p (Fig. S5 D). Next, we introduced mutations 
into GMAPN that altered the amphipathic nature of the ALPS 
motif, either by insertion of two residues to produce a register 
shift or by mutation of hydrophobic residues to alanines or 
aspartates. All of these mutations in GMAPN resulted in a diffuse 
cytosolic localization pattern (Table I), indicating that the am-
phipathic properties of the ALPS motif are required for local-
ization to vesicular structures in yeast cells. Finally, we tested 
the localization of a GMAPN construct in which the ALPS   
Figure 5.  The ALPS motif of GMAP-210 acts 
as a localization determinant to cytoplasmic 
vesicular structures. (A) Localization of a trun-
cated  version  of  GMAPN-mCherry  with  the 
ALPS motif deleted (schematic diagram, left). 
Fluorescence (left) and overlay onto a differ-
ential interference contrast image (right) are 
shown. (B, left) Localization (bottom) of con-
structs  is  shown  in  the  schematic  diagrams 
(top). ALPS–Smc1-CC was constructed by re-
placing the CC region of GMAPN with that 
of the nuclear protein Smc1p (aa 158–374). 
(right) For quantifications, 60–130 structures 
for each GFP fusion protein were scored for 
localization  to  the  nucleus,  as  visualized  by 
Hoechst staining, or to the cytoplasm. Results   
shown  are  representative  of  two  indepen-
dent experiments. Outlines of cells are indi-
cated by dashed lines. (C) Representative EM 
image of cells expressing the ALPS–Smc1-CC–
GFP  chimeric protein. Inset shows a higher 
magnification of the boxed region. BY4742 
cells expressing the indicated proteins were 
grown overnight under inducing conditions 
before imaging.97 Curvature sensors bind vesicles selectively • Pranke et al.
Figure 6.  The first 38 aa of -synuclein act as a localization determinant to peripheral vesicular structures containing endosomal markers. (A) Schematic 
diagrams of the GMAPN-GFP and -synuclein chimera–GFP probes and their localization in yeast cells. (B) Localization of -synuclein chimera–GFP (-syn   
chim) with FM4-64 (top) and Rtn1p-mRFP (bottom) and of -synuclein chimera–mCherry with Lucifer yellow (LY; middle). (A and B) Bars, 2 µm. (C) Quan-
tifications of the experiments shown in B. (D) Strain IPY6 -synuclein chimera–GFP was grown overnight under repressing conditions and then shifted 
(open symbols) or not shifted (closed symbols) to induction medium for the indicated times, and absorbance (Abs) of the cultures at OD600 was monitored.   
(E) BY4742 cells expressing the indicated constructs were grown overnight under inducing conditions and treated with FM4-64, and the level of fluorescent 
signal in vacuolar structures was determined as described in Materials and methods. (F and G) Representative EM images of BY4742 cells expressing 
-synuclein chimera–GFP induced for 16 h. Arrows show vesicular structures. N, nucleus; V, vacuole; CW, cell wall. Means and SDs of at least three 
independent experiments are shown.JCB • VOLUME 194 • NUMBER 1 • 2011   98
(McMahon and Gallop, 2005; Hatzakis et al., 2009; Drin and 
Antonny, 2010; Liu et al., 2010). Whether curvature sensors 
have the capacity to discriminate between membranes of differ-
ent lipid composition is less well explored. Here, we have com-
pared the lipid-binding properties of two amphipathic curvature 
sensors whose chemistries are strikingly different: an ALPS motif 
and -synuclein (Fig. 2, A and B). Comparison of their lipid-
binding properties in vitro confirms that this difference in chem-
istry translates into specific binding to liposomes of different 
composition, complementary to the chemical properties of each 
curvature sensor. Remarkably, when expressed in yeast cells, 
these mammalian curvature sensors specifically target distinct 
classes of vesicles, with properties corresponding to their pre-
ferred in vitro lipid environment.
the endocytic marker FM4-64 at early time points after induction 
(Fig. 8, C and D). Hence, the capacity to cause accumulations of 
early secretory pathway vesicles in yeast cells is not dependent on 
the orientation of the ALPS motif sequence. Together, these   
results support the conclusion that localization of GMAPN to   
vesicular structures in yeast occurs primarily through protein– 
lipid interactions.
Discussion
The  discovery  of  membrane  curvature  sensors  revealed  that 
membrane trafficking could be regulated by membrane shape. 
Studies to date have focused on the principle that membrane 
curvature directs the binding of these sensors to lipid vesicles 
Figure  7.  The  -synuclein  chimeric  probe 
colocalizes  specifically  with  endocytic  and 
post-Golgi  markers.  (A–C)  Localization  of 
the  -synuclein  chimera–GFP  (-syn  chim) 
with  the  indicated  mCherry-tagged  marker. 
Representative images for mCherry-Bos1p (A) 
and mCherry-Snc1p (B) are shown. Quantifi-
cations are depicted in C. Cells were grown 
overnight  under  repressing  conditions  and 
then transferred to induction medium for 2.5 
(A–C) or 4 h (C). Means and SDs of at least 
three  independent  experiments  are  shown. 
Bar, 2 µm.
Table I.  Localization of GMAPN mutants in yeast cells
Protein expressed Mutations Expression level Localization
GMAPN (aa 1–375) None WT Cytoplasmic puncta (EM; vesicle accumulations)
GMAPN (aa 1–375) ALPS L8A WT Diffuse cytoplasmic
GMAPN (aa 1–375) ALPS W4A L5A ≥WT Diffuse cytoplasmic
GMAPN (aa 1–375) ALPS L23D L26D ≥WT Diffuse cytoplasmic
GMAPN (aa 1–375) ALPS ins25AA WT Diffuse cytoplasmic
GMAPN (aa 1–375) ALPS ins25DD WT Diffuse cytoplasmic
GMAPN (aa 39–375) ALPS (1–38) ≥WT Diffuse cytoplasmic (EM; no vesicles accumulated)
GMAPN (aa 1–160) CC truncation (161–377) WT Cytoplasmic puncta (EM; vesicle accumulations)
WT, level of wild-type GMAPN after overnight induction.99 Curvature sensors bind vesicles selectively • Pranke et al.
each fundamental unit. Hence, the dimer of GMAP-210 ALPS   
motifs and -synuclein, both of which have >20 helical turns, 
have a high capacity to sense the subtle differences in lipid 
packing that differentiate highly curved and flatter membranes.
Given the very different chemistries of the AHs formed by 
ALPS motifs and -synuclein, they are ideally suited to sensing 
the different lipid compositions of their target vesicles directly. 
Inversion of the ALPS motif sequence, which preserves specific 
membrane  targeting  but  should  compromise  any  potential 
protein–protein interactions, provides strong support for this 
conclusion. Both secretory vesicles (Zinser et al., 1991; Klemm   
et al., 2009) and endocytic vesicles (Sun et al., 2007) in yeast, 
as in other eukaryotes, have high levels of anionic phospholipids, 
in contrast to vesicles of the early secretory pathway trapped   
by the GMAPN ALPS motif. Hence, the properties of the vesi-
cles that -synuclein and ALPS motifs associate with in cells 
correlate well with their in vitro lipid-binding properties, par-
ticularly in terms of charge (Figs. 2 and 4 D). The differences in 
the hydrophobic faces of ALPS motifs and -synuclein might 
also aid in their discrimination of different types of vesicles. 
ALPS motifs should have a preference for the unsaturated lipids 
of the early secretory pathway, whereas -synuclein with its 
The mechanisms by which ALPS motifs and -synuclein 
sense membrane curvature are on the one hand similar and on the 
other hand opposite. The similarity relies on the strong unbalance 
between the polar and nonpolar face, which exacerbates the need 
for positive membrane curvature. In other words, both GMAPN 
and -synuclein have a weakness that makes positive membrane 
curvature mandatory for their binding, probably because mem-
brane curvature facilitates the insertion of the AH into the mem-
brane interfacial region. However, what renders their lipid binding 
opposite is the fact that -synuclein uses electrostatic interactions 
to overcome the minimal contribution of its hydrophobic face, 
whereas an ALPS motif relies on the hydrophobic force to com-
pensate for its lack of charged polar residues.
The lipid binding of both ALPS motifs and -synuclein 
depends very sharply on liposome size, a property that we pro-
pose is caused by the length and repetitive nature of the AHs 
formed by these two proteins (Antonny, 2011). For an AH of   
n turns, if each turn has the same equilibrium constant K for the 
coupling between folding and adsorption, the equilibrium con-
stant for the adsorption of the entire AH will depend on K
n. This 
repetitive mode of membrane interaction, akin to Velcro, can 
amplify small differences in the lipid-binding properties of   
Figure 8.  Inverting the ALPS motif sequence does not affect the capacity of GMAPN to accumulate early secretory pathway vesicles. (A) The GMAP-210 
ALPS motif sequence and its inverted sequence (top) and their helical wheel representations (bottom). Yellow: Val, Leu, Ile, Met, Phe, and Trp. Pink: Ser and 
Thr. Red: Asp and Glu. Blue: Lys and Arg. Grey: other residues. (B) Representative EM image of cells expressing invALPS-GMAP. Inset shows boxed region 
at a higher magnification. N, nucleus; V, vacuole; CW, cell wall. (C) Localization of invALPS-GMAP–mCherry with GFP-Bet1p after 4 h of induction (top) 
and of invALPS-GMAP–GFP with FM4-64 after 2.5 h of induction (bottom). Bar, 2 µm. (D) Quantification of localization of invALPS-GMAP–mCherry with 
GFP-Bet1p, GFP-Sec22p, or GFP-Emp47p or of invALPS-GMAP–GFP with FM4-64 at the indicated times after induction. SEY6210 (or BY4742 for FM4-64 
imaging) cells carrying the indicated proteins on plasmids were grown overnight under inducing conditions (B) or overnight under repressing conditions 
and shifted to induction medium for 2.5 or 4 h (C and D). Means and SDs of at least three independent experiments are shown. Outlines of cells are indi-
cated by dashed lines. N, N terminus; C, C terminus.JCB • VOLUME 194 • NUMBER 1 • 2011   100
endocytic vesicles containing Snc1p in yeast and may have a 
similar function in neurons, in which it has been reported to 
regulate synaptic vesicle recycling (Ben Gedalya et al., 2009; 
Nemani et al., 2010).
Expression of GMAPN and the -synuclein chimera in 
yeast led to accumulation of vesicles that appeared to be blocked 
before fusion but after uncoating, suggesting that these curva-
ture sensors might be involved in regulating a late step in vesicle 
fusion. -Synuclein has been shown to promote assembly of 
synaptic vesicle SNARE complexes (Burré et al., 2010), which 
is consistent with the idea that it regulates synaptic vesicle fu-
sion. The probes we have described here should provide useful 
tools to explore mechanisms by which curvature sensors might 
regulate fusion of the vesicles that they are targeted to.
Materials and methods
Yeast strains, plasmids, and antibodies
Yeast strains used in this study are shown in Table S1. To optimize GMAPN 
expression in yeast, a synthetic gene was constructed in which all codons 
were changed to those most optimal for yeast. GMAPN, -synuclein, and 
the  -synuclein  chimera  (-synuclein  aa  1–38  fused  to  aa  39–375  of 
GMAPN)  were  fused  to  yeast  EGFP  (yEGFP;  Cormack  et  al.,  1997),   
expressed under the control of the TetO2 promoter in pAP90 (a gift from   
A. Peyroche, Commissariat à l’Energie Atomique, Gif-sur-Yvette, France), 
resulting in plasmids pIP7, pIP29, and pIP119. pIP90, pIP12, and pIP148 
were  constructed  by  transferring  the  TetO2  promoter  cassettes  of  pIP7, 
pIP29, and pIP119 into pRS306 and were integrated at the URA3 locus in 
SEY6210 to generate IPY1, IPY2, and IPY3, respectively. pIP152, pIP153, 
and pIP156 were constructed by first replacing the 3HA tag between sites 
PacI and AscI of pFA6a-His3MX6-PGAL1-GFP-3HA (Longtine et al., 1998) 
with the genes encoding GMAPN-, -synuclein–, and -synuclein chimera–
yEGFP fusions, to place the mammalian yEGFP fusions downstream of the 
PGAL1 promoter. These PGAL1-X–yEGFP cassettes were cloned into pFA6a-
GFP(S65T)-HIS3, replacing the GFP(S65T) gene with PGAL1-X–yEGFP. PCR 
products from reactions using oligonucleotides targeting integration to the 
intergenic region between GAL1 and GAL10, with pIP152, pIP153, or 
pIP156 as templates, were transformed into strains IPY1, IPY2, and IPY3 to 
generate IPY4, IPY5, and IPY6. Strains were grown in YPD (yeast extract 
peptone dextrose) medium with 10 µg/ml doxycycline to repress expres-
sion and induced in YP + 2% galactose.
pIP30 and pIP122 carry mCherry versions of GMAPN and the   
-synuclein chimera, respectively, in pAP901, derived from pAP90 by re-
placement of yEGFP with mCherry. pIP71 and pIP61 carry mCherry fusions   
of GMAPN and -synuclein under control of the TetO2 promoter in pRS425 
(2 LEU2). pIP66 carries GMAPN-mCherry under control of the TetO7 pro-
moter in pCM252 (CEN [centromeric vector] TRP1; Bellí et al., 1998). 
pCM188 and pCM252 were gifts from E. Herrero (Universitat de Lleida, 
Lleida, Spain), and mCherry-N1 was a gift from G. Patterson (National 
Institute  of  Biomedical  Imaging  and  Bioengineering,  Bethesda,  MD).   
A portion of the Smc1p CC (aa 158–374; a gift from D. Koshland, Carn-
egie Institution, Baltimore, MD) and the ALPS motif of GMAP-210 fused its   
N terminus (ALPS–Smc1-CC), deletion and point mutants of GMAPN, and 
the inverted ALPS sequence fused to GMAP-210 aa 39–375 (invALPS-
GMAP) were expressed as yEGFP fusions in plasmids derived from pAP90. 
pIP130  carries  invALPS-GMAP–mCherry  in  pAP901.  Genes  encoding 
Sec4p, Ypt1p, and SNAREs were cloned with yEGFP or mCherry at their 
N termini in pCM252. pIP108–pIP112 were constructed by transferring 
LactC2 (Yeung et al., 2008) and +2, +4, +6, and +8 charge probes (Roy 
et al., 2000; gifts from J. Silvius, McGill University, Montréal, Québec, 
Canada) into pAP90. To repress expression, yeast transformants were 
grown in selective minimal medium with 2% glucose and 10 µg/ml doxy-
cycline; to induce expression, the same medium without doxycycline was 
used. pKSY142 GFP-Emp47p (Sato and Nakano, 2003) and yeast en-
hanced citrine-tagged glycosylated pro–-factor (Castillon et al., 2009) 
were gifts from K. Sato (University of Tokyo, Tokyo, Japan) and H. Riezman 
(University  of  Geneva,  Geneva,  Switzerland).  Mutagenesis  was  per-
formed using a site-directed mutagenesis kit (QuickChange II XL; Agilent 
Technologies). All plasmids constructed in this study were confirmed by 
DNA sequencing.
small hydrophobic face should be accommodated well in mem-
branes with higher levels of saturated phospholipids. This as-
pect awaits further investigation.
The  AHs  formed  by  the  GMAP-210  ALPS  motif  and   
-synuclein represent two extremes of AH structure. Other AHs 
with distinctive chemistries are also adapted to specific cellular 
membranes. The N-terminal AH of epsin, along with residues 
in the adjacent epsin N-terminal homology domain, make direct 
contacts with phosphatidylinositol 4,5-bisphosphate (Ford et al., 
2002). The autoinhibitory AH of CTP:phosphocholine cytidylyl-
transferase binds to and inhibits the catalytic domain of the en-
zyme and is displaced by binding to membranes only when their 
PC content drops below a critical level (Cornell and Taneva, 
2006). Spo20p, a PM SNARE in yeast, has an N-terminal AH 
that acts as a sensor of phosphatidic acid–enriched membranes 
(Nakanishi et al., 2004; Liu et al., 2007). The fact that AHs pene-
trate into the interfacial region of the bilayer, where they interact 
with multiple lipids, allows them to integrate many physico-
chemical parameters of cellular membranes (Antonny, 2011).
AHs also differ in their ability to sense or induce mem-
brane curvature. That ALPS motifs and -synuclein are sens-
ing, rather than inducing, vesicles in yeast cells is supported by 
several observations. In cells expressing these proteins, we ob-
served no increase in the frequency of tubules or budding pro-
files (Figs. 1 and 6). We estimated that the ratio of GMAPN 
protein to phospholipid is 1:1,000 in yeast cells, a ratio at 
which GMAPN does not induce membrane deformations in vitro 
(Drin et al., 2008). If -synuclein was able to form membrane 
vesicles, the -synuclein T6 mutant, with the increased hydro-
phobicity of its nonpolar face, should be even more efficient at 
doing so. However, we found exactly the opposite result: yeast 
cells expressing this mutant accumulated many fewer vesicular 
structures (Figs. 3 and S3). Collectively, our results are most 
consistent with the idea that ALPS motifs and -synuclein are 
curvature sensors both in vitro and in vivo. It is likely that high 
levels of these curvature sensors in cells prevent vesicle fusion 
but not tethering, leading to formation of vesicle clusters, a 
mechanism recently described for clustering of secretory vesi-
cles in yeast (Rossi and Brennwald, 2011).
We demonstrated a high level of specificity in -synuclein 
membrane targeting in yeast cells through the construction of a 
novel -synuclein chimeric probe, based on the design principle 
of GMAPN, in which the 38-aa ALPS motif was replaced with 
the first 38 aa of -synuclein. As previously described by other 
groups (Auluck et al., 2010), we observed localization of   
-synuclein to the PM in addition to vesicular structures. Given 
the strong selectivity of -synuclein for small liposomes in vitro, 
it is unlikely that localization to the relatively flat PM is medi-
ated solely by lipid interaction of its AH and may involve the   
C-terminal region, which is known to interact with protein partners 
(Auluck et al., 2010; Burré et al., 2010). Strong support for this 
conclusion comes from the fact that the -synuclein chimera 
did not localize to the PM but only to vesicular clusters closely 
juxtaposed to the PM (Figs. 6 and 7). Most of these structures 
contained Snc1p, the yeast homologue of VAMP/synaptobrevin, 
whose mechanism of trafficking is conserved from yeast to   
humans (Burston et al., 2009). Hence, -synuclein likely traps 101 Curvature sensors bind vesicles selectively • Pranke et al.
Fluorescence microscopy
Cultures were grown to mid–logarithmic phase in the appropriate medium at 
23°C and then resuspended in fresh synthetic medium and transferred to 
slide chambers (ibidi; Biovalley) precoated with concanavalin A (Sigma- 
Aldrich). Cells were maintained at room temperature and imaged using an 
HCX Plan Apochromat CS 100×, NA 1.40 objective lens on a microscope 
(DM IRE2; Leica) equipped with a 10-MHz charge-coupled device camera 
(CoolSNAPHQ; Roper Scientific) using Metamorph (version 7.6.4.0; Molecu-
lar Devices). Deconvolution of z series was performed and analyzed using 
Metamorph. For quantifications, images were acquired for each condition in 
at least three independent experiments. In yeast cells, between 50 and 200 
puncta (unless otherwise indicated) of GFP- or mCherry-tagged GMAPN,   
-synuclein, or chimeras were scored for the presence or absence of the co-
expressed marker or dye, and the percentage of puncta with the coexpressed 
marker was calculated. All experiments show means and SDs of at least 
three independent experiments. Preliminary experiments and the experiment 
shown in Fig. S4 E were performed with the help of the IMAGIF facility in 
confocal microscopy and flow cytometry, Centre de Recherche de Gif.
EM
For ultrastructural experiments, cells were fixed directly in culture medium 
by addition of 25% glutaraldehyde (Sigma-Aldrich) to a final concentration 
of 0.5% for ≥10 min with shaking. Cells were harvested, washed twice, 
and resuspended in 2% glutaraldehyde, 0.1 M cacodylate, pH 6.8, and   
1 M sorbitol buffer and incubated overnight or longer at 4°C. Cells were 
permeabilized in 1% sodium metaperiodate for 15 min at room tempera-
ture and then postfixed for 1.5 h at room temperature in a 1:1 mixture of 
2% aqueous osmium tetroxide and 3% aqueous potassium ferrocyanide. 
Cells were embedded in 2% agar and dehydrated in graded ethanol baths 
(70–100%) followed by embedding in Epon. 70-nm sections were cut with 
a ultramicrotome (Ultracut UCT; Leica) and counterstained with lead citrate 
for 1.5 min before observation.
For immunogold labeling, cells were fixed in culture medium (see pre-
vious paragraph), washed twice, resuspended in 1% glutaraldehyde caco-
dylate buffer, and incubated at room temperature for 1 h. Cells were washed 
and resuspended in 0.1 M cacodylate, pH 6.8, and 1 M sorbitol buffer. 
Cells were permeabilized in metaperiodate (see previous paragraph) and 
then incubated for 10 min in 50 mM ammonium chloride and washed in 
water before embedding in 2% agar. Dehydration was performed in graded 
ethanol baths (50–100%) followed by embedding in unicryl resin. 90-nm-thick 
sections were blocked in buffer T (20 mm Tris-HCl, 154 mM NaCl, 0.1% 
NaN3, 0.1% BSA, 0.05% Tween 20, and 0.1% fish gelatin), incubated with 
primary GFP antibody (ab290; 1:100; Abcam) in buffer T for 90 min, 
washed, labeled with 10-nm gold-conjugated anti–rabbit secondary anti-
bodies (Sigma-Aldrich), and stained in 5% uranyl acetate for 5 min followed 
by lead citrate for 1.5 min. Images in Figs. 1, 5, and S1 were captured on 
an electron microscope (CM12; FEI) equipped with a 2,048 × 2,048–pixel 
camera (UltraScan1000; Gatan, Inc.) and DigitalMicrograph acquisition 
software (Gatan, Inc.). Images in the remaining figures were obtained using 
a microscope (Morgagni; FEI) fitted with a camera (Morada; Olympus) with 
Soft Imaging Solutions imaging software (Olympus). Images were tiled with 
IMOD Blendmont software (Kremer et al., 1996) and then subjected to   
 and contrast adjustment.
Cell staining, CPY secretion, and immunoprecipitation assays
For  FM4-64  staining  (Vida  and  Emr,  1995),  cells  were  incubated  with   
20 µg/ml FM4-64 (Invitrogen) in YPD medium on ice for 45 min, washed, 
and incubated at 23°C with shaking for 45 min. To quantify the amount of 
FM4-64 accumulated in the vacuolar membranes of cells, images of 10 cells 
per strain were analyzed for each experiment. Using ImageJ software   
(National Institutes of Health), the mean gray value was determined for vacuolar 
membrane regions and for regions of the cytoplasm, and the values for vacuolar 
membranes were normalized against cytoplasmic background levels. Values 
shown are means and SDs of at least three independent experiments. For Lucifer 
yellow and Hoechst staining, BY4742 cells carrying the appropriate plasmid 
were grown overnight (OD600 ≈0.1 for Lucifer yellow staining) in selective   
medium without doxycycline. Cells were spun down and resuspended in YPD 
containing 4 mg/ml Lucifer yellow (Sigma-Aldrich) or in 1 ml Hoechst dye   
(0.5 µg/ml) in fresh selective medium and incubated at 23°C for 2.5 h. After 
washing out the dye, cells were observed in ibidi slide chambers.
To monitor CPY secretion, strains IPY4, IPY5, and IPY6 were grown 
overnight at 23°C in YP medium containing 2% galactose. Cells were 
lysed with glass beads (Sigma-Aldrich) in 20 mM Hepes, pH 7.2, 100 mM 
KCl, 5 mM MgCl2, 1% Nonidet P-40 containing protease inhibitors (GE 
Healthcare), and PMSF (Sigma-Aldrich), and cleared lysates were resolved 
The plasmids expressing the GMAPN mutants shown in Table I were 
derived from pIP7. Transformants were induced overnight, and the level of 
each mutant protein was compared with that of GMAPN by Western blot 
analysis. Mouse monoclonal antibodies GMAP-210/TRIP11 (BD), GFP 
(Roche),  carboxypeptidase  Y  (CPY;  Invitrogen),  and  -synuclein  (BD) 
were used for Western blot analysis, and purified rabbit polyclonal GFP   
(Abcam) was used for immuno-EM.
GMAPN purification and labeling
The N-terminal region of GMAP-210 (aa 1–375; GMAPN) carrying the 
M1C mutation and lacking the four endogenous cysteines (mutations C75L, 
C212S, C350L, and C357L) was expressed in Escherichia coli at 17°C in 
the form of a GST fusion (pGEX-4T2 vector). The fusion protein was purified 
from the bacterial soluble fraction using glutathione beads. After thrombin 
cleavage, the 1–375-aa fragment was labeled with a fivefold molar excess 
of  NBD  iodoacetamide  (Invitrogen)  from  a  stock  solution  in  dimethyl   
formamide (DMF; final DMF volume <5%). The labeled protein was further 
purified by gel filtration chromatography on a Sephacryl S-300 column. 
The  final  purified  product  was  analyzed  by  mass  spectroscopy  and   
N-terminal sequencing, which confirmed the mutations and labeling.
-Synuclein mutagenesis, purification, and labeling
-Synuclein cloned into vector pET21b (not including the His6 tag) and con-
taining the V3C mutation was expressed in E. coli (0.5-liter culture) and puri-
fied  from  the  soluble  fraction  by  a  standard  procedure  that  includes  a 
15-min boiling step to precipitate other proteins. After centrifugation, the   
supernatant, which contained mostly -synuclein (in the range of 100 µM), 
was incubated with a fivefold molar excess of NBD iodoacetamide from a 
stock solution in DMF (DMF volume <5%). After incubation at room tempera-
ture for 10 min and in the dark, 5 mM cysteine was added to quench the 
excess dye. The sample was then dialyzed on a NAP-10 column and further 
purified by 40 ml Q Sepharose chromatography using a NaCl gradient   
(0–1 M). The peak of -synuclein was 95% pure and, according to UV-visible 
absorption spectroscopy, was 100% labeled with NBD. The final purified 
product was analyzed by mass spectroscopy and N-terminal sequencing, 
which confirmed the mutations and labeling.
The T6 form of -synuclein contains six mutations (T22L, T33F, T44L, 
T59L, T81F, and T92L) in addition to the V3C mutation. The protein was 
purified and labeled as for the wild-type form except that its behaviour on 
the Q Sepharose column was completely different, probably because of its 
much higher hydrophobicity. This chromatography step was modified in 
the following way: the NBD-labeled sample was first applied to a small   
Q Sepharose column (8 ml). A large fraction of T6 was not retained on this 
column, so the flow through was then reloaded on a second and larger   
Q Sepharose column (40 ml). Next, a gradient of NaCl (0–1 M) was ap-
plied, which did not elute the T6 mutant but, instead, a few contaminants. 
Last, the T6 mutant was eluted by repeated injections of 6 M guanidine   
(3–5 ml). Each injection resulted in the elution of pure NBD-labeled T6   
-synuclein. The various guanidine fractions were then pooled, dialyzed 
against buffer (50 mM Hepes, pH 7.2, and 120 mM K acetate) and concen-
trated using a filtration system (cutoff of 3 kD; Amicon Ultra-15; Millipore).
Liposome preparation and binding assay
A lipid film containing the desired amount of phospholipids and cholesterol 
was prepared in a rotary evaporator from stock solutions in chloroform 
(Avanti Polar Lipids, Inc.). The film was resuspended in 50 mM Hepes, pH 7.2, 
and 120 mM K acetate at a final concentration of 2 mM phospholipids.   
After five steps of freezing and thawing using liquid nitrogen and a water bath 
at 30°C, the liposomes were sequentially extruded using a hand extruder 
(Avanti Polar Lipids, Inc.) through polycarbonate filters with a pore size of 
200, 100, 50, and 30 nm. Alternatively, the liposomes were sonicated with 
a titanium probe. The size distribution of all liposome suspensions was deter-
mined by dynamic light scattering using a Dynapro apparatus at a final con-
centration  of  0.2  mM  phospholipids.  NBD  fluorescence  emission  was 
recorded at 37°C upon excitation at 505 nm in a fluorimeter (RF5301;   
Shimadzu). All experiments were performed in the following buffer: 50 mM 
Hepes, pH 7.2, 120 mM K acetate, 1 mM MgCl2, and 1 mM DTT. The parti-
tion coefficients of [NBD]GMAPN and [NBD]-synuclein for liposomes of de-
fined size and composition were determined from two independent titration 
experiments (Figs. 2 C and 3 B, insets). The partition coefficient corresponds 
to the amount of free phospholipid that gives 50% binding. For weak bind-
ing, this corresponds to the total phospholipid concentration at which the 
NBD fluorescence change is 50% of maximal. For strong binding, the bind-
ing curves were fitted to a quadratic equation describing the binding of a 
protein to a lipid patch of n lipids with an equilibrium constant K. The parti-
tion coefficient is given by the product nK (Mesmin et al., 2007).JCB • VOLUME 194 • NUMBER 1 • 2011   102
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by SDS-PAGE. Immunoblotting with CPY antibody was followed by chemi-
luminescent detection using ECL Advance Western Blotting Detection kit 
(GE Healthcare). Membranes were imaged using a luminescent image an-
alyzer (LAS-3000; Fujifilm). The levels of the CPY p1 precursor and mature 
form were quantified using ImageJ software. The amount of p1 CPY was 
normalized to total (P1 + mature) CPY. Means and SDs of at least three in-
dependent experiments were determined.
The GMAPN protein/phospholipid ratio in yeast cells was calcu-
lated as follows. The quantity of GMAPN-GFP in cell extracts was quantified 
from Western blots as described in the previous paragraph using ImageJ 
software and determined to be 35.6 ng (0.5 pmol) per 10
6 cells (Fig. S1). 
This quantity corresponds to a concentration of 7.1 µM, assuming a vol-
ume of 70 µm
3 for a Saccharomyces cerevisiae cell (Sherman, 2002). For 
comparison, the total concentration of cytoplasmic actin is 5.3 µM (Kim et 
al., 2004). The total quantity of phospholipids in S. cerevisiae has been 
determined to be 1.03 nmol per 10
6 cells (Ejsing et al., 2009) or 15 mM. 
A conservative estimate is that at least half of yeast phospholipids are in 
bilayers exposed to the cytoplasm, based on calculations of the surface 
area of yeast organelles and the fact that the majority of phospholipids are 
in bilayer membranes (Stace and Ktistakis, 2006; Perktold et al., 2007; 
Bankaitis et al., 2010). Hence, the ratio of GMAPN-GFP protein/phospho-
lipid in bilayers available to bind cytoplasmic GMAPN-GFP is 1:1,000.
Immunoprecipitations were performed as previously described (Deng 
et al., 2009), except that the lysis buffer used was 20 mM Hepes, pH 7.2, 
100 mM KCl, 5 mM MgCl2, and 1% Nonidet P-40. Cleared cell lysates 
were incubated for 1 h at 4°C with GFP or -synuclein antibodies and then 
with protein G–Sepharose (GE Healthcare) for an additional 1 h at 4°C. The 
resin was washed three times with 20 mM Hepes, pH 7.2, 100 mM KCl,   
5 mM MgCl2, and 0.5% Nonidet P-40 and once with PBS.
Online supplemental material
Fig. S1 shows fluorescence and immuno-EM characterization of yeast cells 
expressing GMAPN-GFP and comparison with cells expressing -synuclein–
GFP. Fig. S2 shows that -synuclein, but not GMAPN, requires PS for binding 
to liposomes in vitro. Fig. S3 shows binding of the T6 -synuclein mutant   
to large neutral liposomes and expression of T6 -synuclein in yeast cells.   
Fig. S4 shows that GMAPN, -synuclein, and the -synuclein chimera structures 
do not colocalize with coats in yeast cells. Fig. S5 compares -synuclein and 
the -synuclein chimera localizations and interactions in wild-type yeast, and 
their inhibition in the endocytosis mutant sla2. Table S1 shows yeast strains 
used in this study. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201011118/DC1.
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